FDA Clearance Tracker · P070014-S010
LIFESTENT AND LIFESTENT XL VASCULAR STENT SYSTEMS
Last checked: Nov 20, 2026Latest source record: Dec 23, 2010 (this decision)Source: openFDAMethods & limitations
Decided
Dec 23, 2010
Approved
Time to decision
288 days
Received Mar 10, 2010. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P070014-S010
- Device name
- LIFESTENT AND LIFESTENT XL VASCULAR STENT SYSTEMS
- Applicant
- Bard Peripheral Vascular, Inc.
- Applicant location
- Tempe, AZ
- Received
- Mar 10, 2010
- Decided
- Dec 23, 2010
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P070014
Device type
- Device type
- STENT, SUPERFICIAL FEMORAL ARTERY (NIP)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE LIFESTENT AND LIFESTENT XL VASCULAR STENT SYSTEMS. THE LIFESTENT AND LIFESTENT XL VASCULAR STENT SYSTEMS ARE INTENDED TO IMPROVE LUMINAL DIAMETER IN THE TREATMENT OF SYMPTOMATIC DE-NOVO OR RESTENOTIC LESIONS UP TO 240 MM IN LENGTH IN NATIVE SUPERFICIAL FEMORAL ARTERY (SFA) AND/OR PROXIMAL POPLITEAL ARTERIES WITH REFERENCE VESSEL DIAMETERS RANGING FROM 4.0 ¿ 6.5 MM.
Source documents
Other decisions for Bard Peripheral Vascular, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P250050 · Decided Sep 25, 2026 · 303 days after receipt
Device type: SHUNT, PORTOSYSTEMIC, ENDOPROSTHESIS (MIR) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.